Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Daniela K. van Santen"'
Autor:
Daniela K. van Santen, Rachel Sacks-Davis, Ashleigh Stewart, Anders Boyd, Jim Young, Marc van der Valk, Colette Smit, Andri Rauch, Dominique L. Braun, Inmaculada Jarrin, Juan Berenguer, Jeffrey V. Lazarus, Karine Lacombe, Maria-Bernarda Requena, Linda Wittkop, Olivier Leleux, Dominique Salmon, Fabrice Bonnet, Gail Matthews, Joseph S. Doyle, Tim Spelman, Marina B. Klein, Maria Prins, Jason Asselin, Mark A. Stoové, Margaret Hellard
Publikováno v:
EClinicalMedicine, Vol 56, Iss , Pp 101810- (2023)
Summary: Background: Broad direct-acting antiviral (DAA) access may reduce hepatitis C virus (HCV) incidence through a “treatment as prevention” (TasP) effect. We assessed changes in primary HCV incidence following DAA access among people living
Externí odkaz:
https://doaj.org/article/659605e137e54320885128beb757fa9d
Autor:
Daniela K. van Santen, Roel A. Coutinho, Anneke van den Hoek, Giel van Brussel, Marcel Buster, Maria Prins
Publikováno v:
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-11 (2021)
Abstract The Netherlands is well known for its early adoption of harm reduction (HR) programs at the height of its heroin crisis in the 1970s/1980s, including the implementation of the first needle and syringe program worldwide. In this manuscript, w
Externí odkaz:
https://doaj.org/article/5163d302d5b341a0b22414edf95ce567
Autor:
Ellen Generaal, Hilje Logtenberg van der Grient, Eberhard Schatz, Daniela K. van Santen, Anders Boyd, Sara K. Woods, Bert L. C. Baak, Maria Prins
Publikováno v:
Diagnostics, Vol 11, Iss 7, p 1197 (2021)
People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV) infections and are frequently homeless. To improve HCV case finding in these individuals, we examined the feasibility of rapid HCV RNA testing in homeless servi
Externí odkaz:
https://doaj.org/article/39e610a94afc4724837148544a52db31
Autor:
Daniela K. van Santen, Sara Lodi, Paul Dietze, Wijnand van den Boom, Kanna Hayashi, Huiru Dong, Zishan Cui, Lisa Maher, Matthew Hickman, Anders Boyd, Maria Prins
Publikováno v:
Addiction, 118(6), 1116-1126. Wiley-Blackwell
Background and Aims: Although the Netherlands, Canada and Australia were early adopters of harm reduction for people who inject drugs (PWID), their respective HIV and hepatitis C (HCV) epidemics differ. We measured the pooled effect of needle and syr
Autor:
Margaret Hellard, E.J. Gane, Joseph Doyle, Christopher K Fairley, Jennifer F Hoy, Joe Sasadeusz, Paul A. Agius, David Iser, William Sievert, Richard D. Moore, Daniela K van Santen, Mark OʼReilly, Nicholas A. Medland
Publikováno v:
Journal of acquired immune deficiency syndromes (1999), 85(5), e81-e89. Lippincott Williams and Wilkins
Background Markers of HIV disease severity are associated with increased liver fibrosis in HIV/Hepatitis C virus (HCV) co-infected individuals. HCV treatment may reverse liver fibrosis, but evidence among HIV/HCV-coinfected populations and the impact
Autor:
Anna Lee Wilkinson, Daniela K van Santen, Michael W Traeger, Rachel Sacks-Davis, Jason Asselin, Nick Scott, Brendan L Harney, Joseph S Doyle, Carol El-Hayek, Jessica Howell, Fran Bramwell, Hamish McManus, Basil Donovan, Mark Stoové, Margaret Hellard, Alisa Pedrana
Publikováno v:
International journal on drug policy, 103:103655. Elsevier
Background: Monitoring trends in hepatitis C virus (HCV) incidence is critical for evaluating strategies aimed at eliminating HCV as a public health threat. We estimate HCV incidence and assess trends in incidence over time among primary care patient
Autor:
Anders Boyd, Maria Prins, Daniela K van Santen, Lisa Maher, Matthew Hickman, Sara Lodi, Amy Matser
Publikováno v:
et al. 2021, ' The effect of needle and syringe program and opioid agonist therapy on the risk of HIV, hepatitis B and C virus infection for people who inject drugs in Amsterdam, the Netherlands : findings from an emulated target trial ', Addiction, vol. 116, no. 11, pp. 3115-3126 . https://doi.org/10.1111/add.15503
Addiction, 116(11), 3115-3126. Wiley-Blackwell
Addiction, 116(11), 3115-3126. Wiley-Blackwell
Background and aims Major declines in HIV and hepatitis C and B virus (HCV/HBV) incidence among people who inject drugs (PWID) have been attributed to early implementation of harm‐reduction programs (HRP) in the Netherlands but alternative factors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7740196d06c00d5720056598d5562088
https://research-information.bris.ac.uk/ws/files/270312989/20210120_Effect_HRP_on_HIV_HCV_and_HBV_in_Amsterdam_REVISED_Clean.pdf
https://research-information.bris.ac.uk/ws/files/270312989/20210120_Effect_HRP_on_HIV_HCV_and_HBV_in_Amsterdam_REVISED_Clean.pdf
Autor:
Sara K. Woods, Daniela K van Santen, Eberhard Schatz, Hilje Logtenberg-van der Grient, Anders Boyd, Ellen Generaal, Maria Prins, Bert L. C. Baak
Publikováno v:
Diagnostics
Diagnostics, 11(7):1197. MDPI AG
Diagnostics, Vol 11, Iss 1197, p 1197 (2021)
Volume 11
Issue 7
Diagnostics, 11(7):1197. MDPI AG
Diagnostics, Vol 11, Iss 1197, p 1197 (2021)
Volume 11
Issue 7
People who inject drugs (PWID) are disproportionately affected by hepatitis C virus (HCV) infections and are frequently homeless. To improve HCV case finding in these individuals, we examined the feasibility of rapid HCV RNA testing in homeless servi
Autor:
Carol El-Hayek, Jason Asselin, David J Templeton, James H McMahon, Basil Donovan, David Wilson, Andrew Carr, Jennifer F Hoy, Noah Haber, Margaret Hellard, Julian Elliot, Denton Callander, Daniela K van Santen, Mark Stoove, Hamish McManus, Rebecca Guy, Michael W Traeger, Kathy Petoumenos, Teng Liaw
Publikováno v:
Lancet HIV, 8(10), e623-e632. Elsevier Limited
Summary Background Most studies assessing the HIV care cascade have typically been cross-sectional analyses, which do not capture the transition time to subsequent stages. We aimed to assess the longitudinal HIV cascade of care in Australia, and chan
Autor:
Maria Prins, Giel H. A. van Brussel, Daniela K van Santen, Anneke van den Hoek, Marcel Buster, Roel A. Coutinho
Publikováno v:
Harm Reduction Journal
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-11 (2021)
Harm Reduction Journal, Vol 18, Iss 1, Pp 1-11 (2021)
The Netherlands is well known for its early adoption of harm reduction (HR) programs at the height of its heroin crisis in the 1970s/1980s, including the implementation of the first needle and syringe program worldwide. In this manuscript, we describ